ObsEva SA to Present Model-Based Analysis Supporting Clinical Use of Linzagolix at Doses Not Requiring Hormonal Add back Therapy
ObsEva SA - Common Shares (OBSV)
Last obseva sa - common shares earnings: 3/5 01:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
obseva.com/news/obseva-sa-announces-60-0-million-private-placement-with-existing-and-new-investors
Company Research
Source: GlobeNewswire
Once-daily oral Linzagolix doses of 75 mg and 100 mg without hormonal add-back therapy could lead to symptom relief of endometriosis-association pain and heavy bleeding from uterine fibroids while maintaining bone health 2019 American Conference on Pharmacometrics Quality Award Winning Abstract Geneva, Switzerland and Boston, MA – October 11, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise woman’s reproductive health and pregnancy, today announced upcoming clinical data presentations on linzagolix at multiple medical meetings, including: -13th European Society of Gynecology (ESG) Congress: October 16-19 in Vienna, Austria.Oral Presentation, Thursday, October 17 at 11:45 a.m. CET “Is hormonal add-back necessary? A model-based analysis to guide gonadotropin-releasing hormone (GnRH) receptor antagonist use for management of
Show less
Read more
Impact Snapshot
Event Time:
OBSV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OBSV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OBSV alerts
High impacting ObsEva SA - Common Shares news events
Weekly update
A roundup of the hottest topics